June 2000
Worldwide Biotech;Jun2000, Vol. 12 Issue 6, p7
Trade Publication
Reports that Immtech International Inc. is establishing a research consortium focused on developing treatments for Leishmaniasis, a parasite-transmitted disease that affects people in arid countries.


Related Articles

  • Biotech startup rides fast track. Somasundaram, Meera // Crain's Chicago Business;04/24/2000, Vol. 23 Issue 17, p3 

    Reports on the stock performance of Chicago, Illinois-based biotechnology firm Immtech International Inc. Share price of Immtech stocks following the decline in the stock prices of other high technology industries; Business strategies; Funding secured by the firm from public and private investors.

  • Cash woes afflict local medical firm. Klein, Sarah A. // Crain's Chicago Business;03/12/2001, Vol. 24 Issue 11, p4 

    Reports on the financial problems suffered by Vernon Hills, Illinois-based biotechnology company Immtech International Inc. Need for the firm to raise more venture capital by June 2001; Range of treatments for life-threatening diseases that are being developed by the firm.

  • Immtech adds Imidazoline receptor binding compounds to indication platform.  // PharmaWatch: CNS;March 2004, Vol. 3 Issue 3, p5 

    Focuses on the patent received by Immtech International Inc. from U.S. and Australian regulatory officials regarding aromatic amidine compounds targeting Imidazoline receptors in the brain. Licence of aromatic amidine compounds; Potential treatment of the drug for Alzheimer's disease;...

  • IMMTECH DISCOVERS ORAL TREATMENT FOR TYPE 2 DIABETES.  // Biotech Business;Jan2002, Vol. 15 Issue 1, p2 

    Reports that the Scientific Consortium of Immtech International has identified a class of compounds with the potential to be used as an oral alternative to insulin injections for the treatment of type 2 diabetes.

  • IMMTECH REPORTS NET LOSS FOR 4TH QTR. AND FISCAL 2000.  // Biotech Financial Reports;Aug2000, p1 

    Focuses on the financial performance of Vernon Hills, Illinois-based biopharmaceutical firm Immtech International Inc. for the fourth quarter ended March 31, 2000. Comparison with 1999 figures; Specialization on the delivery of drugs for the treatment of fungal diseases, cancer, tuberculosis,...

  • Chicago's largest public companies.  // Crain's Chicago Business;12/29/2003, Vol. 26 Issue 52, p33 

    This article presents statistical information on, and ranking of, largest public companies in Chicago, Illinois. Revenue increase registered by Immtech International Inc. was 159.9%, Middlefay Corp. registered a 125.6% percent increase, while Midway Games Inc. registered an increase of 65.4%....

  • WEEKLY CLOSE.  // Crain's Chicago Business;1/17/2005, Vol. 28 Issue 3, p4 

    This article presents statistics related to stock prices of several business enterprises in Illinois. Some of the companies are American Pharmaceutical, Immtech International, CCC Information Services, AMCOL International Corp., Inforte Corp., MFRI Inc., NeoPharm Inc., Northfield Laboratories...

  • WEEKLY CLOSE.  // Crain's Chicago Business;3/7/2005, Vol. 28 Issue 10, p4 

    This article presents statistical information on the stock performance of several companies in the U.S. Some of the companies listed are, USF Corp., Telular Corp., A.M. Castle & Co., Immtech International Inc., Hartmax Corp., Navistar International, NovaMed Inc., General Binding Corp.,...

  • In Afghanistan, Tackling Leishmaniasis--and Narcotics.  // UN Chronicle;Mar-May2003, Vol. 40 Issue 1, p63 

    Focuses on the risk of leishmaniasis parasite infection among women and children in Kabul, Afghanistan. Resistance levels of returning refugees; Appeal launched by the World Health Organization for funds; Need of funding to launch a program for the prevention of leishmaniasis.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics